By Priscila Mayumi Kashiwabara

Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that … Life sciences patent eligibility in Latin America: a guide

On February 8th, 2022, the Brazilian Patent Office reported the decision to apostille letters-patent when the patent protects subject-matter going beyond the … News on apostille of letters-patent retroactively affected by the Direct Plea of Unconstitutionality 5,529

On December 28, 2021, the BRPTO published, by means of the Official Gazette nº 2660, the Ordinance #56/2021, which establishes the procedures … Sequence listing in ST.26 format is officially postponed until July 1, 2022 by the Brazilian PTO

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara authored the chapter "Personalised medicine in Brazil: IP and regulatory challenges". This article first … Personalised medicine in Brazil: IP and regulatory challenges

Continuing with the goal of reducing the number of patent applications pending decision, the Brazilian PTO (“BPTO”) published the Ordinance/INPI/PR N° 21, … Brazilian PTO extends the Patent Backlog Fighting Project

According to a joint note released by the Ministry of Foreign Affairs and the Ministry of the Environment, Brazil deposited, on the … Biodiversity: Brazil deposits instrument of ratification at the UN and Nagoya Protocol will enter into force in Brazil soon

On December 2, 2020, through its Commission on Narcotics, the United Nations approved a recommendation issued by WHO – World Health Organization … UN removes Cannabis from List of Narcotic Substances

The Revised Guidelines for the Examination of Patent Applications in the Biotechnology Field (Normative Instruction INPI/PR n° 118/2020) finally entered into force … Revised Guidelines for the Examination of Patent Applications in the Biotechnology field in force

The Brazilian FDA (ANVISA) published on November 19, 2020, four manuals regarding the analysis of prior consent of patent applications related to … ANVISA published manuals related to prior consent of patent applications

As informed on our Newsletter #03, on February 2019, the BRPTO started public hearing proceedings regarding the revised Guidelines for the Examination … Updates regarding public hearing about guidelines for the Examination of Patent Applications in the Biotechnology field

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil … Biologics and biosimilars in Brazil – the strategic questions

As part of the “Patent Backlog-fighting Project”, the Brazilian Patent and Trademark Office (BPTO) published Resolutions INPI Nos. 240/19 and 241/19 on … BPTO publishes resolutions that will initiate the “Patent Backlog-fighting Project”

On February 6, 2019, the BRPTO started public hearing proceedings regarding the revised Guidelines for the Examination of Patent Applications in the … Public hearing about the guidelines for the examination of patent applications in the biotechnology field

As an alternative to accelerate the examination of patent applications in several areas, the Brazilian Patent Office (INPI) has published Resolution INPI/PR … INPI establishes pilot project of PPH INPI-UKIPO

Published on May 11, 2016, the Decree # 8,772/16 regulates Law #13,123/2015, which provides rules for the access to genetic resources and traditional knowledge and benefit sharing for the conservation and sustainable use of biodiversity.